Appetite disorder was mined in pharmacovigilance of adverse psychiatric events with GLP-1 RA (Chen et al., 2024), we hypothesized that other effects, such as increased appetite and anorexia, could have arisen during agonism of GLP-1 receptor in the nucleus of the solitary tract (NTS). The gene discussed is GLP1R; the disease is Anorexia.